Dr David Lissauer of the Institute of Metabolism and Systems Research writes for the Birmingham Brief on how maternal health suffers from some of the most stark health inequalities.
Scientists at the University of Birmingham have found that increased male hormones result in women with polycystic ovaries having a two-fold increased risk of developing non-alcoholic fatty liver disease.
A trial led by the University of Birmingham has found that two types of blood thinning drugs are safe to use in patients with an irregular heartbeat when they are undergoing surgery aimed at stopping the condition.
A recently-formed health consortium, jointly led by the National Institute for Health Research Birmingham Biomedical Research Centre (NIHR Birmingham BRC) and NHS Wales, has been awarded £7 million by Innovate UK to ensure more patients benefit from a new generation of breakthrough therapies.
Dr Rachel Bayley, a Research Fellow within the Institute of Cancer and Genomic Sciences.
Researchers at the University of Birmingham and King's College London have found that staying active keeps the body young and healthy.
Birmingham research into the development of vaccines against bacterial infections has been highlighted during a visit to campus by the International Development Minister.
Dr Myriam Chimen has been awarded a 5-year Royal Society Dorothy Hodgkin Research Fellowship to investigate the glucocorticoid regulation of a novel pathway controlling T-cell trafficking in chronic inflammatory diseases and ageing.
A study jointly led by the University of Birmingham and University of Edinburgh has revealed that a new scanning technology could almost halve the number of liver biopsies carried out on people with fatty liver disease.
The University of Birmingham will play a leading role in a new £2.3 million clinical trial aimed at improving treatment to prevent potentially deadly bleeding in patients with liver cirrhosis.
School-based healthy lifestyle interventions alone are not effective in the fight against childhood obesity, researchers at the University of Birmingham have warned.
Changes have been recommended to international guidelines used in the development of clinical trials in an effort to gain information about the impact of the treatment on participating patients and their quality of life.